Patient Data: Emerging Opportunities for Rare Diseases, Cell & Gene Therapies and Oncology

Patient data has the potential to transform all aspects of life sciences product development and commercialization. In this session, you will hear from the CEO of a cell and gene therapy company with a late-stage investigational therapeutic for a rare disease. He will present his perspectives on how patient data can be transformative for rare disease product development and commercialization. He will be joined by two additional expert panelists who will add their views on this evolving subject.

– Discussion topics will evaluate the benefits of patient data for:

– Rare Disease and Cell & Gene Therapy-

– New Product Launches

– Commercial and Medical Affairs initiatives

– Clinical Development and Regulatory Affairs

– Patient finding, HEOR and other use cases

Scroll to Top

Connect with us